BCTXL BriaCell Therapeutics Corp. - Warrants

NASDAQ ·
$0.88
Price · Aug 19, 2026

BCTXL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.88
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$1 – $1

BCTXL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
BCTXL
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
BCTXL
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
BCTXL
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
BCTXL
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
BCTXL
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
BCTXL
Peer Median

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 10 filers · $2.5M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
0 5 1 4

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.

Institution Value Shares % of tracked 13F Type
CITADEL ADVISORS LLC $716,781 895,864 28.29% Shares
ARMISTICE CAPITAL, LLC $477,574 536,600 18.85% Shares
Cable Car Capital, LP $286,489 321,898 11.31% Shares
Empery Asset Management, LP $267,000 300,000 10.54% Shares
MYDA Advisors LLC $174,281 195,821 6.88% Shares
SABBY MANAGEMENT, LLC $169,441 190,383 6.69% Shares
HEIGHTS CAPITAL MANAGEMENT, INC $149,284 186,582 5.89% Shares
Warberg Asset Management LLC $142,004 159,555 5.61% Shares
Clear Street Group Inc. $92,734 104,196 3.66% Shares
IRIDIAN ASSET MANAGEMENT LLC/CT $57,850 65,000 2.28% Shares

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Marc Lustig, L5 Capital Inc. Sept. 7, 2021 Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.